Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07818421) titled 'Intratumoral Microbiota and Immune Microenvironment in Prostate Cancer' on Sept. 8.

Study Type: Observational

Primary Sponsor: Anhui Medical University

Condition: Prostate Cancer Adenocarcinoma

Intervention: Diagnostic Test: Validate spatial localization of candidate microbial signals via 16S rRNA ISH, FISH, immunofluorescence, IHC, and spatial omics.

Recruitment Status: Not recruiting

Date of First Enrollment: October 1, 2026

Target Sample Size: 100

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07818421

Published by HT Digital Content Services with permission f...